Bioclinica Predicts Demand for TQT Trials in China
Bioclinica has partnered with a Chinese hospital citing growing regulatory pressure for cardiac safety studies in the country as the key driver.
Bioclinica has partnered with a Chinese hospital citing growing regulatory pressure for cardiac safety studies in the country as the key driver.
CRO Parexel’s massive backlog could position the company for continued revenue growth moving forward, top executives said at recent conferences.
Teva has affirmed its respiratory drug delivery strategy with the purchase of MicroDose Therapeutx for a potential $165m (€123m).
The UK MHRA plans to let drugmakers import APIs that lack ‘written confirmation’ of quality if there is an overriding need to ensure continued supply.
MPI Research, inviCRO and 3D Imaging are partnering to combine their imaging tools at a new center in Michigan aimed at large biopharma clients.
UPDATE
Shasun Pharmaceuticals’ says it is trying to restart operations at the earliest opportunity after workers went on strike at its API and formulation facility in India last Sunday.
A GlaxoSmithKline subsidiary has issued a recall of two batches of Ventolin syrup in the UK after glass fragments were found in some bottles.